New Cannabis and Cannabinoid Research Journal Commends President Obama’s Signal of Support for Medical Marijuana

Discussion in 'Marijuana News' started by jainaG, Sep 1, 2015.

  1. http://www.liebertpub.com/global/pressrelease/new-cannabis-and-cannabinoid-research-journal-commends-president-obamas-signal-of-support-for-medical-marijuana/1682/


    New Rochelle, NY, June 25, 2015- Mary Ann Liebert, publisher of the newly launched peer-reviewed open access journal Cannabis and Cannabinoid Research,
    strongly supports President Obama's statement that "…carefully
    prescribed medical use of marijuana may in fact be appropriate and we
    should follow the science as opposed to ideology on this issue,” when
    asked about a pending Senate bill seeking to change federal law
    regarding state-legalized medical marijuana programs. Cannabis and Cannabinoid Research, a fully open access journal will be the authoritative source for research, discussion, and debate. Mary Ann Liebert, Inc., publishers
    will publish the Journal under the Creative Commons Attribution 4.0 (CC
    BY) license to ensure broad dissemination and participation.
    Cannabis and Cannabinoid Research will
    publish fully peer-reviewed, evidence-based original articles, review
    articles, and perspectives on cannabis, cannabinoids, and the
    endocannabinoid system. The Journal will publish a broad range of human
    and animal studies including basic and translational research; clinical
    studies; behavioral, social, and epidemiological issues; and ethical,
    legal, and regulatory controversies.

    An interdisciplinary community including pharmacologists and
    psychopharmacologists, toxicologists, biochemists, neurologists,
    psychiatrists, physicians, and other healthcare practitioners, addiction
    specialists, and regulators and policymakers are invited to participate
    in this new open access resource.

    Topics in Cannabis and Cannabinoid Research
    will include: Biochemical process of the endocannabinoid system •
    Cannabinoid receptors and signaling • Pharmaceuticals based on cannabis
    and cannabinoids • Optimal dosing and drug delivery • Short- and
    long-term effects on the brain and behavior • Toxicological studies •
    Analgesic effects, including neuropathic pain and chronic nerve injury •
    Neurological disorders, including epilepsy, multiple sclerosis, and
    glaucoma • Use of cannabis as antinauseants and antispasmodics • Immune
    function and chronic inflammation, including HIV • Cancer and
    cancer-related treatment • Screening and assessment for marijuana misuse
    and addiction • Social, behavioral, and public health impact • Ethics,
    regulation, legalization, and public policy.

    Cannabis and Cannabinoid Research will
    build a central forum and repository for peer-reviewed open access
    papers, as more high-quality research is needed to move the field
    forward.
    “Cannabis research and its applications for therapy will create new challenges as its promise is evaluated,” says Mary Ann Liebert,
    founder, President, and CEO of the company that bears her name.
    “Scientists in the lab and those on the front lines of patient care now
    have an important new educational forum. Cannabis and Cannabinoid Research, which is fully open access, will be the Journal of record.”

    For information on manuscript submission or to sign up for email alerts for Cannabis and Cannabinoid Research, please contact us.

    About the Publisher
    Mary Ann Liebert, Inc., publishers
    is a privately held, fully integrated media company known for
    establishing authoritative peer-reviewed journals in many promising
    areas of science and biomedical research, including Journal of Medicinal Food, The Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News
    (GEN), was the first in its field and is today the industry's most
    widely read publication worldwide. A complete list of the firm's 80
    journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

     

Share This Page